BIO appoints second-in-command
Executive Summary
Biotechnology Industry Organization is finalizing a title for former HHS Chief of Staff Scott Whitaker, who recently joined BIO as the number two executive under CEO James Greenwood (1"The Pink Sheet" Feb. 21, 2005, In Brief). Although BIO says Whitaker's official title has not yet been finalized, the group's website identifies Whitaker as the executive vice president. At a recent Center for Global Development meeting at Covington & Burling in Washington, D.C., Whitaker was introduced as BIO's exec VP and chief operating officer...
You may also be interested in...
BIO names exec VP-health
Former FDA Deputy Commissioner for Policy Amit Sachdev joins the Biotechnology Industry Organization as executive VP for health April 18. Sachdev left FDA March 25. BIO is finalizing the details of a new top-level organizational structure, with an announcement expected the week of April 18. The association also has named former House Energy & Commerce Committee Majority Counsel Brent Delmonte as VP for legislative affairs and former HHS Chief of Staff Scott Whitaker as CEO Jim Greenwood's second-in-command (1"The Pink Sheet" April 11, 2005, In Brief)...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.